| 11/16/2026 11:15 PM | Turn Therapeutics (2023016) Filer | Form EFFECT | |
| 11/16/2026 11:15 PM | Turn Therapeutics (2023016) Filer | Form EFFECT | |
| 11/16/2026 3:40 PM | Turn Therapeutics (2023016) Filer | Form 424B5 | |
| 11/10/2026 7:05 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/09/2026 7:00 AM | Turn Therapeutics (2023016) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 11/09/2026 7:05 AM | Turn Therapeutics (2023016) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 11/09/2026 6:00 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/09/2026 6:02 AM | Turn Therapeutics (2023016) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/19/2026 3:15 PM | Turn Therapeutics (2023016) Filer | Form ARS | |
| 10/19/2026 3:05 PM | Turn Therapeutics (2023016) Filer | Form DEF 14A | |
| 09/10/2026 7:10 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for TTRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Turn Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/09/2026 7:10 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/26/2026 3:42 PM | Turn Therapeutics (2023016) Filer | Form D Notice of Exempt Offering of Securities | |
| 08/18/2026 7:30 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/17/2026 3:14 PM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/12/2026 3:40 PM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/12/2026 3:50 PM | Turn Therapeutics (2023016) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/07/2026 7:05 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/08/2026 4:30 PM | Kester Kent Edward (2087469) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 4:30 PM | GOLDEN ARTHUR F (1023260) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 4:31 PM | Gengos Andrew (1563623) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 4:31 PM | Dewhurst Martin William (2108597) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 5:12 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/01/2026 5:06 PM | BEB Holdings, LLC (2087363) Reporting Burnam Bradley Evan (2087366) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 7:45 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/27/2026 7:10 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/19/2026 7:15 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 7:15 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/12/2026 8:33 PM | Turn Therapeutics (2023016) Filer | Form C-TR | |
| 05/11/2026 3:17 PM | Turn Therapeutics (2023016) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/06/2026 7:05 AM | Burnam Bradley Evan (2087366) Filed by Turn Therapeutics (2023016) Subject | Form SCHEDULE 13G | |
| 04/03/2026 7:06 AM | Chaudhary Zuraiz (2086494) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 7:07 AM | BEB Holdings, LLC (2087363) Reporting Burnam Bradley Evan (2087366) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 7:08 AM | GOLDEN ARTHUR F (1023260) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 7:09 AM | BEB Holdings, LLC (2087363) Reporting Burnam Bradley Evan (2087366) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 11:15 PM | Turn Therapeutics (2023016) Filer | Form EFFECT | |
| 04/02/2026 11:15 PM | Turn Therapeutics (2023016) Filer | Form EFFECT | |
| 03/31/2026 3:59 PM | Turn Therapeutics (2023016) Filer | Form POS AM | |
| 03/31/2026 3:53 PM | Turn Therapeutics (2023016) Filer | Form POS AM | |
| 03/31/2026 3:30 PM | Turn Therapeutics (2023016) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/31/2026 3:18 PM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Why I'm selling my Snapback Indicator for just $7 (Ad) For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500.
The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long.
No strings attached, and Wood says there is an unusual reason behind the steep discount. Get lifetime access to the Snapback Indicator for a one-time $7 payment today. |
| 03/24/2026 7:17 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 7:10 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/09/2026 7:44 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/04/2026 6:30 AM | Dewhurst Martin William (2108597) Reporting Turn Therapeutics (2023016) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/04/2026 6:31 AM | Dewhurst Martin William (2108597) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 7:12 AM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/07/2026 3:18 PM | Turn Therapeutics (2023016) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/12/2025 5:00 PM | Chaudhary Zuraiz (2086494) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 8:00 PM | GOLDEN ARTHUR F (1023260) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 4:43 PM | Chaudhary Zuraiz (2086494) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 8:23 PM | Chaudhary Zuraiz (2086494) Reporting Turn Therapeutics (2023016) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 3:05 PM | Turn Therapeutics (2023016) Filer | Form 424B3 | |
| 11/17/2025 3:06 PM | Turn Therapeutics (2023016) Filer | Form 424B3 | |